Pharmaceutical-grade cannabinoid infrastructure for U.S. healthcare
NuNature Labs was built to operate in the United States, where many of these standards are not required, but were deliberately adopted to support medical channels and institutional partnerships. Our vertically integrated platform spans U.S.-based cGAP cultivation and breeding, cGMP API production, and cGMP pharmaceutical grade manufacturing, aligned with global pharmaceutical expectations, including FDA, EU GMP, and ANVISA CBPF.
U.S. Grown Hemp
cGMP API + cGMP Finished Products
DEA controlled substance lab manufacturing
ANVISA-Regulated Market Experience
cGAP Cultivation & Breeding
Evidence-Ready Clinical Pathway
Our Purpose
At NuNature Labs, our purpose is to advance pharmaceutical-grade cannabinoid science while supporting healthcare partners in delivering safer, more consistent options for patients and families with unmet needs.
​
We develop pharmaceutical-grade controlled cannabinoid products for serious, high-need use cases where variability and over-the-counter nutraceutical approaches are not acceptable. Through disciplined cultivation, manufacturing controls, and clinical development, we translate cannabinoid science into evidence-driven healthcare programs where outcomes, safety, and documentation matter.
We Are
A pharmaceutical grade cannabinoid platform built for regulated healthcare spanning cGAP cultivation and breeding, cGMP API production, and cGMP pharmaceutical grade manufacturing, supported by a documentation first approach and evidence readiness.
We Are Not
An over-the-counter nutraceutical supplier, a direct-to-consumer CBD retailer, or a recreational cannabis company.
Demonstrated performance in regulated channels
In Brazil, NuNature’s cannabinoid products have been commercialized within a regulated healthcare framework, supported by professional medical materials and pharmacy-channel distribution. This experience reflects our commitment to clinical oversight and regulated governance in international markets.
​
Regulatory status and availability vary by market. Information is provided for institutional evaluation only and does not imply U.S. authorization.
Our platform is designed to deliver consistency, governance, and scalability across the full lifecycle from inputs to evidence.
cGAP Cultivation & Breeding
Controlled inputs start at the source.
We apply disciplined U.S.-based cultivation and breeding practices to support repeatability, traceability, and supply chain governance suitable for institutional partnerships.
cGMP Pharmaceutical Grade Manufacturing
Pharmaceutical-grade finished dosage forms.
Finished products are manufactured under pharmaceutical-grade quality systems aligned with regulated-market expectations, enabling consistent presentations for clinically supervised channels.
cGMP API Production
Standardized API production.
API manufacturing is designed around documentation, defined specifications, and predictable quality attributes supporting program-level repeatability and consistency.
Clinical + Evidence Readiness
Evidence-led development.
Our development roadmap spans formulation and stability through preclinical safety and Phase I–III clinical evaluation, complemented by real-world evidence frameworks for payer and institutional partners.
A structured development approach
Our science-driven approach follows a structured pathway designed to support credible evaluation, documentation, and partner governance across regulated healthcare environments.
Our development framework is designed to support both clinical research programs and payer-relevant evidence generation. Each stage emphasizes standardization, documentation, and oversight, enabling responsible evaluation and scalable deployment without reliance on consumer or nutraceutical models.
​
✓ Formulation development
✓ Supply chain qualification
✓ Stability and quality assessment
✓ Manufacturing readiness
✓ Preclinical evaluation
✓ Clinical and real-world evidence planning
Partner ecosystem
An ecosystem built for regulated execution
NuNature Labs collaborates with an established network across manufacturing, analytics, clinical operations, and distribution, supporting evaluation of a platform designed for quality systems, documentation, and real-world execution.
